References Search
All References with Titles containing 'Monks_TJ' OR with Authors including 'Monks_TJ' OR with Abstract including 'Monks_TJ' OR with Keywords including 'Monks_TJ'
| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Miller RT, Serrine SL, Mo... |
Metabolism of 5-(Glutathion-S-yl)-a-methyldopamine Following Intracere... |
Chem Res Toxicol |
1995 |
| Miller RT, Lau SS, Monks ... |
Effects of intracerebroventricular administration of 5-(glutathion-S-y... |
Chem Res Toxicol |
1996 |
| Miller RT, Lau SS, Monks ... |
2,5-bis-(Glutathion-S-yl)-alpha-methyldopamine, a putative metabolite ... |
Eur J Pharmacol |
1997 |
| Bai F, Lau SS, Monks TJ |
Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine pr... |
Chem Res Toxicol |
1999 |
| Monks TJ, Ghersi-Egea JF,... |
Symposium overview: the role of glutathione in neuroprotection and neu... |
Toxicol Sci |
1999 |
| Bai F, Jones DC, Lau SS, ... |
Serotonergic Neurotoxicity of 3,4-(+/-)-Methylenedioxyamphetamine and ... |
Chem Res Toxicol |
2001 |
| Carvalho M, Hawksworth G,... |
Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vi... |
Arch Toxicol |
2002 |
| Carvalho M, Milhazes N, R... |
Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopami... |
Arch Toxicol |
2003 |
| de la Torre R, Farre M, M... |
Response to Sprague and Nichols: Contribution of metabolic activation ... |
Trends in Pharmacolo... |
2005 |
